Chemotherapy-Free Combo Is Tested in CLLChemotherapy-Free Combo Is Tested in CLL
To avoid the toxicity of chemotherapy for chronic lymphocytic leukemia (CLL), standard rituximab treatment was combined with lenalidomide. The results disappointed an expert. Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
More News: Cancer & Oncology | Chemotherapy | Chronic Leukemia | Chronic Lymphocytic Leukemia | Hematology | Leukemia | Revlimid | Rituxan | Toxicology